8-bromo cyclic adenosine monophosphate has been researched along with Disease Exacerbation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hosoi, H; Imoto, I; Inazawa, J; Inoue, J; Kitagawa, M; Misawa, A; Sugimoto, T; Sugino, Y | 1 |
1 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Disease Exacerbation
Article | Year |
---|---|
Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Alprostadil; Cell Growth Processes; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; Dinoprostone; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; Neuroblastoma; Promoter Regions, Genetic; Receptors, Immunologic; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; RNA, Messenger | 2007 |